What is the J code for rituximab 10 mg?
The CMS has assigned new J-codes for RITUXAN and RITUXAN HYCELA. J9312: Injection, rituximab,10 mg J9311: Injection, rituximab 10 mg (replaces J-code J9310)and hyaluronidase IMPORTANT: Please note that J-code, J9312, will replace J9310 for RITUXAN and the billable units will change from 100 mg to 10 mg.
What are the risks of Rituxan hycela?
Rituximab products can increase your risk of getting infections and can lower the ability of your immune system to fight infections. Types of serious infections that can happen with RITUXAN HYCELA include bacterial, fungal, and viral infections.
What is rituximab and hyaluronidase human?
Rituximab and hyaluronidase human is a combination of rituximab, a CD20-directed cytolytic antibody, and hyaluronidase human, an endoglycosidase. Dose and frequency should be in accordance with the FDA label or recognized compendia (for off-label uses).
What is the code for rituximab-pvvr?
INJECTION, RITUXIMAB-PVVR, BIOSIMILAR, (RUXIENCE), 10 MG Q5123 INJECTION, RITUXIMAB-ARRX, BIOSIMILAR, (RIABNI), 10 MG Group 2 Group 2 Paragraph N/A Group 2 Codes Code Description J3590 UNCLASSIFIED BIOLOGICS J9312 INJECTION, RITUXIMAB, 10 MG
What is J code J9312?
HCPCS code J9312 for Injection, rituximab, 10 mg as maintained by CMS falls under Chemotherapy Drugs.
How do I bill Truxima?
HCPCS Code for Injection, rituximab-abbs, biosimilar, (Truxima), 10 mg Q5115.
What is the J code for Rituximab-PVVR?
Rituximab-Pvvr Injection, for Intravenous Use (Ruxience™) HCPCS Code J9999: Billing Guidelines.
What is the CPT code for Inflectra?
Group 1CodeDescriptionJ1745INJECTION, INFLIXIMAB, EXCLUDES BIOSIMILAR, 10 MGQ5103INJECTION, INFLIXIMAB-DYYB, BIOSIMILAR, (INFLECTRA), 10 MGQ5104INJECTION, INFLIXIMAB-ABDA, BIOSIMILAR, (RENFLEXIS), 10 MGQ5121INJECTION, INFLIXIMAB-AXXQ, BIOSIMILAR, (AVSOLA), 10 MG
What is the J code for Truxima?
Group 2CodeDescriptionJ3590UNCLASSIFIED BIOLOGICSJ9312INJECTION, RITUXIMAB, 10 MGQ5115INJECTION, RITUXIMAB-ABBS, BIOSIMILAR, (TRUXIMA), 10 MGQ5119INJECTION, RITUXIMAB-PVVR, BIOSIMILAR, (RUXIENCE), 10 MG
What is J code J3490?
Meloxicam Injection, for Intravenous Use (Anjeso™) HCPCS Code J3490: Billing Guidelines.
What is CPT code J1569?
Group 1CodeDescriptionJ1569INJECTION, IMMUNE GLOBULIN, (GAMMAGARD LIQUID), NON-LYOPHILIZED, (E.G., LIQUID), 500 MGJ1572INJECTION, IMMUNE GLOBULIN, (FLEBOGAMMA/FLEBOGAMMA DIF), INTRAVENOUS, NON-LYOPHILIZED (E.G., LIQUID), 500 MG8 more rows
What is Q5119?
The RUXIENCE HCPCS code Q5119 is described as “Injection, rituximab-pvvr, biosimilar, (Ruxience), 10 mg.” Each dose increment of 10 milligrams equals 1 billing unit.
What is code J9999?
J9999 is a valid 2022 HCPCS code for Not otherwise classified, antineoplastic drugs or just “Chemotherapy drug” for short, used in Medical care.
What is CPT code Q5104?
Infliximab-abda for Injection, for Intravenous Use (Renflexis® ) HCPCS code Q5104: Billing Guidelines.
What is CPT code J9299?
HCPCS code J9299 should be used to report nivolumab for the Part A and B MAC.
What is CPT J0129?
HCPCS code J0129 for Injection, abatacept, 10 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) as maintained by CMS falls under Drugs, Administered by Injection .
Can rituximab cause a viral infection?
Severe, including fatal, bacterial, fungal, and new or reactivated viral infections can occur during and following the completion of therapy with rituximab-containing products, including RITUXAN HYCELA. Withhold and institute appropriate anti-infective therapy.
Can rituximab cause abdominal pain?
Abdominal pain, bowel obstruction, and perforation, in some cases leading to death, can occur in patients receiving rituximab-containing products, including RITUXAN HYCELA, in combination with chemotherapy. Consider and evaluate for abdominal pain, vomiting, or related symptoms
What is a rituximab hycelia?
RITUXAN HYCELA is a combination of rituximab and hyaluronidase human. Rituximab is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab has a binding affinity for the CD20 antigen of approximately 8.0 nM. Rituximab is produced by mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium that may contain the antibiotic gentamicin. Gentamicin is not detectable in the final product. Recombinant human hyaluronidase is an endoglycosidase used to increase the dispersion and absorption of co-administered drugs when administered subcutaneously. It is produced by mammalian (Chinese Hamster Ovary) cells containing a DNA plasmid encoding for a soluble fragment of human hyaluronidase (PH20). It is a glycosylated single-chain protein with an approximate molecular weight of 61 kD. RITUXAN HYCELA (rituximab and hyaluronidase human) Injection is a colorless to yellowish, clear to opalescent solution supplied in sterile, preservative-free, single-dose vials for subcutaneous administration. RITUXAN HYCELA is supplied as 1,400 mg rituximab and 23,400 Units hyaluronidase human per 11.7 mL in single-dose vials or 1,600 mg rituximab and 26,800 Units hyaluronidase human per 13.4 mL in single-dose vials. Each mL of solution contains rituximab (120 mg), hyaluronidase human (2,000 Units), L-histidine (0.53 mg), L-histidine hydrochloride monohydrate (3.47 mg), L-methionine (1.49 mg), polysorbate 80 (0.6 mg), α,α-trehalose dihydrate (79.45 mg), and Water for Injection.
What are the adverse reactions of Rituximab?
Hematologic: prolonged pancytopenia, marrow hypoplasia, Grade 3–4 prolonged or late-onset neutropenia, hyperviscosity syndrome in Waldenstrom's macroglobulinemia, prolonged hypogammaglobulinemia Cardiac: fatal cardiac failure Immune/Autoimmune Events: uveitis, optic neuritis, systemic vasculitis, pleuritis, lupus-like syndrome, serum sickness, polyarticular arthritis, and vasculitis with rash. Infection: viral infections, including progressive multifocal leukoencephalopathy (PML), increase in fatal infections in HIV-associated lymphoma, and a reported increased incidence of Grade 3 and 4 infections Neoplasia: disease progression of Kaposi's sarcoma. Skin: severe mucocutaneous reactions.Gastrointestinal: bowel obstruction and perforation.Pulmonary: fatal bronchiolitis obliterans and fatal interstitial lung disease.
How long does it take for B cells to return to normal after rituximab?
In patients treated with rituximab for hematological malignancies, B cell recovery began within 6 months of treatment and generally returned to normal levels within 12 months after completion of therapy, although in some patients this may take longer.
How much Rituximab should I take for DLBCL?
Premedicate before each dose [see Dosage and Administration (2.5)].The recommended dose for DLBCL is RITUXAN HYCELA 1,400 mg/23,400 Units (1,400 mg rituximab and 23,400 Units hyaluronidase human) at a fixed dose irrespective of patient's body surface area in combination with CHOP chemotherapy. Administer RITUXAN HYCELA 1,400 mg/23,400 Units on Day 1 of Cycles 2–8 of CHOP chemotherapy for up to 7 cycles following a full dose of a rituximab product by intravenous infusion at Day 1, Cycle 1 of CHOP chemotherapy (i.e., up to 6–8 cycles in total).
Can rituximab cause fetal harm?
Based on human data, rituximab-containing products can cause fetal harm due to B-cell lymphocytopenia in infants exposed to rituximab in-utero. Advise pregnant women of the risk to a fetus. Females of childbearing potential should use effective contraception while receiving RITUXAN HYCELA and for 12 months following the last dose of rituximab-containing products, including RITUXAN HYCELA.
Is RITUXAN HYCELA a live virus?
The safety of immunization with live viral vaccines following rituximab-containing products, including RITUXAN HYCELA, therapy has not been studied and vaccination with live virus vaccines is not recommended before or during treatment.
Can rituximab cause bowel obstruction?
Abdominal pain, bowel obstruction and perforation, in some cases leading to death, can occur in patients receiving rituximab-containing products, including RITUXAN HYCELA, in combination with chemotherapy. In postmarketing reports, the mean time to documented gastrointestinal perforation was 6 (range 1–77) days. Evaluate if symptoms of obstruction such as abdominal pain or repeated vomiting occur.
How long does it take for a rash to appear after a Rituxan injection?
These reactions sometimes happen more than 24 hours after an injection of RITUXAN HYCELA.
How long after a last dose of Rituxan can you give birth?
Females who are able to become pregnant should use effective birth control (contraception) during treatment with RITUXAN HYCELA and for 12 months after the last dose of RITUXAN HYCELA.
How long after a rituxan can you breastfeed?
Do not breastfeed during treatment and for at least 6 months after your last dose of RITUXAN HYCELA. These are not all of the possible side effects with RITUXAN HYCELA. Call your doctor for medical advice about side effects.
How long does it take for a low antibody level to show up after a hycelia treatment?
After receiving RITUXAN HYCELA, some people have developed low levels of certain antibodies in their blood for a long period of time (long er than 11 months). Some of these people with low antibody levels developed infections.
Can you monitor your heart after taking Rituxan?
Your healthcare provider may monitor your heart during and after treatment with RITUXAN HYCELA if you have symptoms of heart problems or have a history of heart problems. Tell your healthcare provider right away if you have chest pain or irregular heartbeats during treatment with RITUXAN HYCELA.
Where to report side effects of Genentech?
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
Can rituximab cause allergic reactions?
Serious allergic reactions and other severe reactions: Serious allergic reactions, and reactions due to release of certain substances by your body that can lead to death, can happen with rituximab products, including RITUXAN HYCELA. Skin reactions at or near the injection site (local), including injection site reactions can happen ...
NDC Package Code 50242-108-01
The NDC Code 50242-108-01 is assigned to a package of 1 vial, single-dose in 1 carton > 11.7 ml in 1 vial, single-dose of Rituxan Hycela, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.
NDC HCPCS Crosswalk
This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.
Other Product Packages
The following packages are also available for Rituxan Hycela with product NDC 50242-108.
